| Redwood Of Blue River | |
| 10425 Chestnut Dr, Kansas City, Missouri 64137 | |
| (816) 763-4444 | |
| Name | Redwood Of Blue River |
|---|---|
| Location | 10425 Chestnut Dr, Kansas City, Missouri |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 160 |
| Occupancy Rate | 68.88% |
| Medicare ID (CCN) | 265597 |
| Legal Business Name | Nursing & Rehab At Chestnut Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1043336738 |
| Organization Name | BLUE RIVER REHABILITATION CENTER, LLC |
| Doing Business As | BLUE RIVER REHABILITATION CENTER |
| Address | 10425 Chestnut Dr, Kansas City, MO 64137 |
| Phone Number | 816-763-4444 |
News Archive
A new study finds that only 36% of cancer patients ages 65 and older participate in clinical trials, despite making up 60% of the U.S. cancer population. The study will be published November 15 in the Journal of Clinical Oncology (JCO).
When is it appropriate to perform genetic testing for Alzheimer disease, and what information do patients need to understand their risk? The June issue of Genetics in Medicine, the official peer-reviewed journal of The American College of Medical Genetics presents a new practice guideline on genetic counseling and testing for AD.
MicroStockProfit.com announces an investment report featuring Encorium Group Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
Aterovax SA, a company developing innovative products for atherosclerosis, today announced the signing of a 3 year, exclusive agreement with SPI-Bio, a specialist distributor of products and services in drug development, to distribute and sell Aterovax's sPLA2 activity test in Europe to academic and research laboratories for research use.
The world's leading expert on the opium poppy has joined forces with researchers working on another infamous drug-producing plant – cannabis – in hopes of finding new uses for the much-maligned sources of heroin and marijuana.
› Verified 8 days ago
| NPI Number | 1043921091 |
| Organization Name | 10425 OPCO LLC |
| Address | 10425 Chestnut Dr, Kansas City, MO 64137 |
| Phone Number | 816-763-4444 |
News Archive
A new study finds that only 36% of cancer patients ages 65 and older participate in clinical trials, despite making up 60% of the U.S. cancer population. The study will be published November 15 in the Journal of Clinical Oncology (JCO).
When is it appropriate to perform genetic testing for Alzheimer disease, and what information do patients need to understand their risk? The June issue of Genetics in Medicine, the official peer-reviewed journal of The American College of Medical Genetics presents a new practice guideline on genetic counseling and testing for AD.
MicroStockProfit.com announces an investment report featuring Encorium Group Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
Aterovax SA, a company developing innovative products for atherosclerosis, today announced the signing of a 3 year, exclusive agreement with SPI-Bio, a specialist distributor of products and services in drug development, to distribute and sell Aterovax's sPLA2 activity test in Europe to academic and research laboratories for research use.
The world's leading expert on the opium poppy has joined forces with researchers working on another infamous drug-producing plant – cannabis – in hopes of finding new uses for the much-maligned sources of heroin and marijuana.
› Verified 8 days ago
| NPI Number | 1245230689 |
| Organization Name | BLUE RIVER CARE CENTER, LLC |
| Doing Business As | BLUE RIVER CARE CENTER |
| Address | 10425 Chestnut Dr, Kansas City, MO 64137 |
| Phone Number | 816-763-4444 |
News Archive
A new study finds that only 36% of cancer patients ages 65 and older participate in clinical trials, despite making up 60% of the U.S. cancer population. The study will be published November 15 in the Journal of Clinical Oncology (JCO).
When is it appropriate to perform genetic testing for Alzheimer disease, and what information do patients need to understand their risk? The June issue of Genetics in Medicine, the official peer-reviewed journal of The American College of Medical Genetics presents a new practice guideline on genetic counseling and testing for AD.
MicroStockProfit.com announces an investment report featuring Encorium Group Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
Aterovax SA, a company developing innovative products for atherosclerosis, today announced the signing of a 3 year, exclusive agreement with SPI-Bio, a specialist distributor of products and services in drug development, to distribute and sell Aterovax's sPLA2 activity test in Europe to academic and research laboratories for research use.
The world's leading expert on the opium poppy has joined forces with researchers working on another infamous drug-producing plant – cannabis – in hopes of finding new uses for the much-maligned sources of heroin and marijuana.
› Verified 8 days ago
| NPI Number | 1528710712 |
| Organization Name | BLUE RIVER MO CONSULTING LLC |
| Doing Business As | POLARIS HEALTH & WELLNESS OF BLUE RIVER |
| Address | 10425 Chestnut Dr, Kansas City, MO 64137 |
| Phone Number | 816-363-6222 |
News Archive
A new study finds that only 36% of cancer patients ages 65 and older participate in clinical trials, despite making up 60% of the U.S. cancer population. The study will be published November 15 in the Journal of Clinical Oncology (JCO).
When is it appropriate to perform genetic testing for Alzheimer disease, and what information do patients need to understand their risk? The June issue of Genetics in Medicine, the official peer-reviewed journal of The American College of Medical Genetics presents a new practice guideline on genetic counseling and testing for AD.
MicroStockProfit.com announces an investment report featuring Encorium Group Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
Aterovax SA, a company developing innovative products for atherosclerosis, today announced the signing of a 3 year, exclusive agreement with SPI-Bio, a specialist distributor of products and services in drug development, to distribute and sell Aterovax's sPLA2 activity test in Europe to academic and research laboratories for research use.
The world's leading expert on the opium poppy has joined forces with researchers working on another infamous drug-producing plant – cannabis – in hopes of finding new uses for the much-maligned sources of heroin and marijuana.
› Verified 8 days ago
| NPI Number | 1841738598 |
| Organization Name | NURSING & REHAB AT CHESTNUT LLC |
| Doing Business As | REDWOOD OF BLUE RIVER |
| Address | 10425 Chestnut Dr, Kansas City, MO 64137 |
| Phone Number | 816-763-4444 |
News Archive
A new study finds that only 36% of cancer patients ages 65 and older participate in clinical trials, despite making up 60% of the U.S. cancer population. The study will be published November 15 in the Journal of Clinical Oncology (JCO).
When is it appropriate to perform genetic testing for Alzheimer disease, and what information do patients need to understand their risk? The June issue of Genetics in Medicine, the official peer-reviewed journal of The American College of Medical Genetics presents a new practice guideline on genetic counseling and testing for AD.
MicroStockProfit.com announces an investment report featuring Encorium Group Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
Aterovax SA, a company developing innovative products for atherosclerosis, today announced the signing of a 3 year, exclusive agreement with SPI-Bio, a specialist distributor of products and services in drug development, to distribute and sell Aterovax's sPLA2 activity test in Europe to academic and research laboratories for research use.
The world's leading expert on the opium poppy has joined forces with researchers working on another infamous drug-producing plant – cannabis – in hopes of finding new uses for the much-maligned sources of heroin and marijuana.
› Verified 8 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
A new study finds that only 36% of cancer patients ages 65 and older participate in clinical trials, despite making up 60% of the U.S. cancer population. The study will be published November 15 in the Journal of Clinical Oncology (JCO).
When is it appropriate to perform genetic testing for Alzheimer disease, and what information do patients need to understand their risk? The June issue of Genetics in Medicine, the official peer-reviewed journal of The American College of Medical Genetics presents a new practice guideline on genetic counseling and testing for AD.
MicroStockProfit.com announces an investment report featuring Encorium Group Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
Aterovax SA, a company developing innovative products for atherosclerosis, today announced the signing of a 3 year, exclusive agreement with SPI-Bio, a specialist distributor of products and services in drug development, to distribute and sell Aterovax's sPLA2 activity test in Europe to academic and research laboratories for research use.
The world's leading expert on the opium poppy has joined forces with researchers working on another infamous drug-producing plant – cannabis – in hopes of finding new uses for the much-maligned sources of heroin and marijuana.
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $9750 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 12.33 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 4.64 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 27.52 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.86 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 3.22 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 1.82 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 0.71 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 96.19 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 2.27 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 49.31 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0.71 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 12.72 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 18.9 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 6.76 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.97 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 62.63 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 71.63 | 82.93 |
News Archive
A new study finds that only 36% of cancer patients ages 65 and older participate in clinical trials, despite making up 60% of the U.S. cancer population. The study will be published November 15 in the Journal of Clinical Oncology (JCO).
When is it appropriate to perform genetic testing for Alzheimer disease, and what information do patients need to understand their risk? The June issue of Genetics in Medicine, the official peer-reviewed journal of The American College of Medical Genetics presents a new practice guideline on genetic counseling and testing for AD.
MicroStockProfit.com announces an investment report featuring Encorium Group Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
Aterovax SA, a company developing innovative products for atherosclerosis, today announced the signing of a 3 year, exclusive agreement with SPI-Bio, a specialist distributor of products and services in drug development, to distribute and sell Aterovax's sPLA2 activity test in Europe to academic and research laboratories for research use.
The world's leading expert on the opium poppy has joined forces with researchers working on another infamous drug-producing plant – cannabis – in hopes of finding new uses for the much-maligned sources of heroin and marijuana.
› Verified 8 days ago
Swope Ridge Geriatric Center Location: 5900 Swope Parkway, Kansas City, Missouri 64130 Phone: (816) 333-2700 | |
Highland Rehabilitation & Health Care Center Location: 904 East 68th Street, Kansas City, Missouri 64131 Phone: (816) 333-5485 | |
Grand Pavilion At The Plaza Location: 4330 Washington, Kansas City, Missouri 64111 Phone: (816) 753-6800 | |
Ignite Medical Resort Carondelet Llc Location: 621 Carondelet Drive, Kansas City, Missouri 64114 Phone: (816) 941-1300 | |
New Mark Care Center Location: 11221 North Nashua Drive, Kansas City, Missouri 64155 Phone: (816) 734-4433 | |